LakeShore Biopharma (LSB)
NASDAQ:LSB
US Market
Holding LSB?
Track your performance easily

LakeShore Biopharma (LSB) Financial Statements

78 Followers

LakeShore Biopharma Financial Overview

LakeShore Biopharma's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; LakeShore Biopharma is scheduled to report earnings on January 27, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Mar 23Sep 22Jun 22Mar 22
Income Statement-
Total Revenue---$ 0.00$ 0.00
Gross Profit-----
EBIT---$ -410.67K$ -233.70K
EBITDA---$ -410.67K$ -233.70K
Net Income Common Stockholders---$ 1.72M$ 7.13M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 246.35M$ 53.90M$ 226.77M$ 615.94K$ 720.22K
Total Assets$ 1.51B$ 250.27M$ 1.55B$ 200.93M$ 200.81M
Total Debt$ 424.46M$ 72.56M$ 461.56M$ 0.00$ 0.00
Net Debt$ 178.11M$ 18.66M$ 234.80M$ -615.94K$ -720.22K
Total Liabilities$ 927.82M$ 144.26M$ 2.50B$ 11.40M$ 13.00M
Stockholders Equity$ 585.21M$ 728.45M$ -950.69M$ 189.53M$ 187.81M
Cash Flow-
Free Cash Flow---$ -104.28K$ -164.98K
Operating Cash Flow---$ -104.28K$ -164.98K
Investing Cash Flow-----
Financing Cash Flow-----
Currency in USD

LakeShore Biopharma Earnings and Revenue History

LakeShore Biopharma Debt to Assets

LakeShore Biopharma Cash Flow

LakeShore Biopharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis